SPG vs UTHR · rev $3.55B vs P/E 20, rev $1.56B
SPG (SPG) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
SPG (SPG) common stock.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
SPG currently screens at market cap $0. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the SPG and UTHR stock pages for the full models.
Not investment advice.